Your browser doesn't support javascript.
loading
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of ELX-02 in Healthy Subjects.
Leubitz, Andi; Vanhoutte, Frederic; Hu, Ming-Yi; Porter, Kaela; Gordon, Efrat; Tencer, Kathleen; Campbell, Kathleen; Banks, Kate; Haverty, Tom.
Afiliación
  • Leubitz A; Eloxx Pharmaceuticals, Inc, Waltham, Massachusetts, USA.
  • Vanhoutte F; SGS Life Sciences, Clinical Pharmacology Unit, Antwerp, Belgium.
  • Hu MY; Eloxx Pharmaceuticals, Inc, Waltham, Massachusetts, USA.
  • Porter K; Consultant to Eloxx Pharmaceuticals, Inc, Waltham, Massachusetts, USA.
  • Gordon E; Eloxx Pharmaceuticals, Inc, Waltham, Massachusetts, USA.
  • Tencer K; Eloxx Pharmaceuticals, Inc, Waltham, Massachusetts, USA.
  • Campbell K; Consultant to Eloxx Pharmaceuticals, Inc, Waltham, Massachusetts, USA.
  • Banks K; Eloxx Pharmaceuticals, Inc, Waltham, Massachusetts, USA.
  • Haverty T; Eloxx Pharmaceuticals, Inc, Waltham, Massachusetts, USA.
Clin Pharmacol Drug Dev ; 10(8): 859-869, 2021 08.
Article en En | MEDLINE | ID: mdl-33465285
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Furanos Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Pharmacol Drug Dev Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Furanos Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Pharmacol Drug Dev Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos